Skip to Main Content

Author Details

Glenn A Walter
College of Medicine, University of Florida
1991
139
45
PMIDPaper TitleJournal TitlePublished Year
37932907Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy.Ann Clin Transl Neurol2024
36331178Magnetic resonance quantification of skeletal muscle lipid infiltration in a humanized mouse model of Duchenne muscular dystrophy.NMR Biomed2023
37483011A comprehensive study of skeletal muscle imaging in FHL1-related reducing body myopathy.Ann Clin Transl Neurol2023
37534782Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials.CPT Pharmacometrics Syst Pharmacol2023
34536384Characterizing Expiratory Respiratory Muscle Degeneration in Duchenne Muscular Dystrophy Using MRI.Chest2022
35466946Step Activity Monitoring in Boys with Duchenne Muscular Dystrophy and its Correlation with Magnetic Resonance Measures and Functional Performance.J Neuromuscul Dis2022
35681116Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging.BMC Cardiovasc Disord2022
36480060Isolated murine skeletal muscles utilize pyruvate over glucose for oxidation.Metabolomics2022
36240102Evaluating Genetic Modifiers of Duchenne Muscular Dystrophy Disease Progression Using Modeling and MRI.Neurology2022
34841594Effects of muscle damage on <sup>31</sup> phosphorus magnetic resonance spectroscopy indices of energetic status and sarcolemma integrity in young mdx mice.NMR Biomed2022
33295018Safety, feasibility, and efficacy of strengthening exercise in Duchenne muscular dystrophy.Muscle Nerve2021
33796064Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests.Front Neurol2021
33678513Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trial.Neuromuscul Disord2021
33861953A form of muscular dystrophy associated with pathogenic variants in JAG2.Am J Hum Genet2021
34326809Corrigendum: Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests.Front Neurol2021
34013753Postcontractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy.J Appl Physiol (1985)2021
34087166A form of muscular dystrophy associated with pathogenic variants in JAG2.Am J Hum Genet2021
33394000Assessment of rAAVrh.74.MHCK7.micro-dystrophin Gene Therapy Using Magnetic Resonance Imaging in Children With Duchenne Muscular Dystrophy.JAMA Netw Open2021
33155691Skeletal muscle magnetic resonance imaging in Pompe disease.Muscle Nerve2021
32286193Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.Radiology2020
32024675MR biomarkers predict clinical function in Duchenne muscular dystrophy.Neurology2020
31929119Characterizing Enrollment in Observational Studies of Duchenne Muscular Dystrophy by Race and Ethnicity.J Neuromuscul Dis2020
32035137Diaphragm weakness and proteomics (global and redox) modifications in heart failure with reduced ejection fraction in rats.J Mol Cell Cardiol2020
32737968Magnetic Resonance Imaging Studies in Duchenne Muscular Dystrophy: Linking Findings to the Physical Therapy Clinic.Phys Ther2020
32184340Modeling disease trajectory in Duchenne muscular dystrophy.Neurology2020
32108365Conference report on contractures in musculoskeletal and neurological conditions.Muscle Nerve2020
32538860Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study.J Neuromuscul Dis2020
32132110MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.Cancer Res2020
31105339Texture Analysis for Muscular Dystrophy Classification in MRI with Improved Class Activation Mapping.Pattern Recognit2019
31350642Imaging respiratory muscle quality and function in Duchenne muscular dystrophy.J Neurol2019
30714967Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI.J Neuromuscul Dis2019
30946638Effects of PDE5 inhibition on dystrophic muscle following an acute bout of downhill running and endurance training.J Appl Physiol (1985)2019
30790036Magnetic resonance imaging characteristics of injection site reactions after long-term subcutaneous delivery of drisapersen.Eur J Pediatr2019
30848538Age-dependent changes in metabolite profile and lipid saturation in dystrophic mice.NMR Biomed2019
29146412Skeletal muscle overexpression of nicotinamide phosphoribosyl transferase in mice coupled with voluntary exercise augments exercise endurance.Mol Metab2018
29554116Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy.PLoS One2018
29742798Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history.Muscle Nerve2018
29734234Two-Year Longitudinal Changes in Lower Limb Strength and Its Relation to Loss in Function in a Large Cohort of Patients With Duchenne Muscular Dystrophy.Am J Phys Med Rehabil2018
29365354Leg muscle MRI in identical twin boys with duchenne muscular dystrophy.Muscle Nerve2018
27778157Magnetic resonance imaging of the proximal upper extremity musculature in boys with Duchenne muscular dystrophy.J Neurol2017
28228973Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy.PLoS Curr2017
29774305Multi-slice MRI reveals heterogeneity in disease distribution along the length of muscle in Duchenne muscular dystrophy.Acta Myol2017
29271299Contrast-Enhanced Near-Infrared Optical Imaging Detects Exacerbation and Amelioration of Murine Muscular Dystrophy.Mol Imaging2017
29018835<sup>13</sup>C/<sup>31</sup>P MRS Metabolic Biomarkers of Disease Progression and Response to AAV Delivery of hGAA in a Mouse Model of Pompe Disease.Mol Ther Methods Clin Dev2017
28669118Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy.J Neurol2017
28826559Magnetic Resonance Monitoring of Disease Progression in mdx Mice on Different Genetic Backgrounds.Am J Pathol2017
28045071Magnetic Resonance Microscopy (MRM) of Single Mammalian Myofibers and Myonuclei.Sci Rep2017
25846867Age-related T2 changes in hindlimb muscles of mdx mice.Muscle Nerve2016
26549781MRI quantifies neuromuscular disease progression.Lancet Neurol2016
28018975Disease-modifying effects of orally bioavailable NF-<b>κ</b>B inhibitors in dystrophin-deficient muscle.JCI Insight2016
  • 1 - 50 of 139

Recommended Authors

Agah Karakuzu
Institut de Cardiologie de Montreal, Universite de Montreal
Career Start Year 2016
Number of shared co-authors 0
David G??mez-Andr??s
Vall d'Hebron University Hospital and VHIR (Euro-NMD
Career Start Year 2013
Number of shared co-authors 1
Joshua D Kaggie
University of Cambridge
Career Start Year 2011
Number of shared co-authors 0
Erin K Englund
Children's Hospital Colorado, University of Colorado Anschutz Medical Campus
Career Start Year 2011
Number of shared co-authors 1
Ian Welch
University of British Columbiagrid.17091.3e
Career Start Year 2008
Number of shared co-authors 0
Andr??s Hern??ndez
Scripps Research Institute
Career Start Year 2007
Number of shared co-authors 0
Xiaoyu Da
Biomedical Imaging Research Institute, Cedars-Sinai Medical Center
Career Start Year 2003
Number of shared co-authors 0
Luke M Judge
Gladstone Institutes
Career Start Year 2002
Number of shared co-authors 0
Stephen J P Pratt
University of Maryland School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Mathieu Boudreau
Montreal Heart Institute
Career Start Year 1998
Number of shared co-authors 0
Robert Bartha
The University of Western Ontario
Career Start Year 1997
Number of shared co-authors 0
Petra Kaufmann
Novartis Gene Therapies
Career Start Year 1994
Number of shared co-authors 2
Kate Bushby
Institute of Genetic Medicine, International Centre for Life
Career Start Year 1991
Number of shared co-authors 5
Karl G Helmer
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1991
Number of shared co-authors 0
Usha Sinha
San Diego State University
Career Start Year 1989
Number of shared co-authors 0
Giuseppe D'Antona
University of Pavia
Career Start Year 1989
Number of shared co-authors 0
Mark A Tarnopolsky
McMaster University Medical Center
Career Start Year 1988
Number of shared co-authors 4
Sharmila Majumdar
University of California san francisco
Career Start Year 1986
Number of shared co-authors 0
Francesco Muntoni
UCL Great Ormond Street Institute of Child Health
Career Start Year 1985
Number of shared co-authors 8
Peter A Hardy
University of Kentucky
Career Start Year 1985
Number of shared co-authors 0
Karyn A Esser
University of Florida
Career Start Year 1984
Number of shared co-authors 2
Felix W Wehrli
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1984
Number of shared co-authors 1
Basil T Darras
Boston Children's Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 4
Slobodan Macura
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 0
Paul M Matthews
UK Dementia Research Institute Centre at Imperial College London
Career Start Year 1981
Number of shared co-authors 0
Thomas A Rando
Stanford University
Career Start Year 1981
Number of shared co-authors 0
Ronald M Peshock
University of Texas Southwestern Medical Center
Career Start Year 1979
Number of shared co-authors 0
John A Hodgson
Walter Reed National Military Medical Center
Career Start Year 1977
Number of shared co-authors 0
Frank W Booth
University of Missouri, USA Dalton Cardiovascular Research Center
Career Start Year 1969
Number of shared co-authors 1
Hanns Lochm??ller
Children's Hospital of Eastern Ontario Research Institute
Career Start Year 1963
Number of shared co-authors 4

Collaborators

Hugh Lee Sweeney
College of Medicine, University of Florida
Co-authored papers 36
William T Triplett
College of Public Health and Health Professions, University of Florida
Co-authored papers 23
Abhinandan Batra
University of Florida
Co-authored papers 17
Richard S Finkel
Center for Experimental Neurotherapeutics, St. Jude Children's Research Hospital
Co-authored papers 11
Huadong Zeng
University of Florida
Co-authored papers 6
Elisabeth R Barton
University of Florida
Co-authored papers 5
David W Hammers
University of Florida
Co-authored papers 5
Volker Straub
Translational and clinical research, Newcastle University Faculty of Medical Sciences
Co-authored papers 4
Stephen E Borst
and Clinical Center
Co-authored papers 3
Terence R Flotte
Co-authored papers 3
Eric S Goetzman
Co-authored papers 2
Arthur S Edison
Co-authored papers 2
Jerry Vockley
Co-authored papers 2
Ram B Khattri
University of Florida
Co-authored papers 2
Eleina England
Co-authored papers 2
Ben Weisburd
Broad Institute of MIT and Harvard
Co-authored papers 2
Anne O'Donnell-Luria
Broad Institute of MIT and Harvard
Co-authored papers 2
Eric W Klee
Mayo Clinic College of Medicine and Science
Co-authored papers 2
Spencer C Henley-Beasley
University of Florida
Co-authored papers 1
Scott A Shaffer
Co-authored papers 1
Kevin P Campbell
Co-authored papers 1
Caroline M Williams
University of California berkeley
Co-authored papers 1
Qiushi Tang
Co-authored papers 1
Cora Hart
University of Florida
Co-authored papers 1
Julie S Cohen
Kennedy Krieger Institute
Co-authored papers 1
Ray A Spradlin
University of Florida
Co-authored papers 1
Zoe White
University of British Columbia
Co-authored papers 1
Christian Mueller
Co-authored papers 1
Jason Puglise
College of Health & Human Performance, University of Florida
Co-authored papers 1
Stanley F Nelson
university of california los angeles
Co-authored papers 1
Release 1.2